Retina/Vitreous

Top Story

AbbVie, Mylan enter patent license agreement for biosimilar adalimumab product

July 17, 2018

Xbrane, Stada enter co-development deal for Xlucane

July 16, 2018
Xbrane Biopharma and Stada Arzneimittel will co-develop Xlucane, a Lucentis biosimilar, according to a press release. Under the co-development agreement, the companies…
In the Journals

In phase 1 study, ICON-1 intravitreal injections safe in eyes with neovascular AMD

July 11, 2018
Intravitreal injections of ICON-1 in eyes with neovascular age-related macular degeneration were found to be safe and well-tolerated in doses up to 300 µg. The…

FDA clears Alleye AMD monitoring application

July 9, 2018
The FDA has issued 510(k) clearance of Alleye, a mobile medical software application, Oculocare medical announced in a press release. Alleye is designed to detect and…
More Headlines »
Clinical Science Imaging

Errors in Thickness Comparison Maps From 3D Optical Coherence Tomography

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
To study characteristics of errors in thickness comparison maps (TCMs) from three-dimensional optical coherence…
More »
CME

Proliferative and Nonproliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment

This activity is supported by an educational grant from Genentech, Inc.

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of…
More »
Resource Centers
Video
Meeting News

VIDEO: Foundation progresses in fighting inherited retinal diseases

July 9, 2018
More »

AbbVie, Mylan enter patent license agreement for biosimilar adalimumab product

July 17, 2018
AbbVie has entered a patent license agreement with Mylan regarding its proposed biosimilar adalimumab product, according to a press release. Under…

Xbrane, Stada enter co-development deal for Xlucane

July 16, 2018
Xbrane Biopharma and Stada Arzneimittel will co-develop Xlucane, a Lucentis biosimilar, according to a press release. Under the co-development…

In the Journals

In phase 1 study, ICON-1 intravitreal injections safe in eyes with neovascular AMD

July 11, 2018
Intravitreal injections of ICON-1 in eyes with neovascular age-related macular degeneration were found to be safe and well-tolerated in doses up to…

FDA clears Alleye AMD monitoring application

July 9, 2018
The FDA has issued 510(k) clearance of Alleye, a mobile medical software application, Oculocare medical announced in a press release. Alleye is…

Meeting NewsVideo

VIDEO: Foundation progresses in fighting inherited retinal diseases

July 9, 2018
NEWPORT BEACH, Calif. — Jason Menzo, chief operating officer of the Foundation Fighting Blindness, the leading private funder of research for…

June's top 5 retina stories

July 6, 2018
June’s most read articles focusing on retina news included breaking news regarding a new IOL for patients with AMD, as well as regulatory and…

Meeting NewsVideo

VIDEO: Allegro preps to move into phase 3 trial with DME treatment

July 5, 2018
NEWPORT BEACH, Calif. — Vicken Karageozian, MD, president and chief medical officer for Allegro Ophthalmics, discusses the progress of the

Meeting NewsVideo

VIDEO: Aerie continues push in glaucoma, retina products

July 3, 2018
NEWPORT BEACH, Calif. Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, delivers an update on the company’s

In the JournalsPerspective

Low endophthalmitis rate found after intravitreal injections

July 2, 2018
Analysis of 12 years of data on intravitreal injections in a large tertiary referral center showed a low rate of endophthalmitis as a complication…

Read OSN’s June 25 publication exclusives online

July 1, 2018
The cover story of the June 25 issue of Ocular Surgery News focused on treating diabetic macular edema. Here are a few of the issue’s…

BioTime receives NIH grant for retinal restoration program

June 29, 2018
The NIH awarded a grant of $743,345 to BioTime to advance its next-generation retinal restoration program, according to a press release. The award…

In the JournalsPerspective

Majority of top Acthar Gel prescribers received manufacturer payments

June 29, 2018
Among rheumatologists, nephrologists and neurologists who issued more than 10 prescriptions for corticotropin in 2015, 88% received payments from its…

In the Journals

Patients may tolerate plain gut sutures better than polyglactin 910 sutures

June 28, 2018
Data from a prospective study showed patients experienced improved tolerability and reduced inflammation if they received plain gut suture after…

Lin Bioscience’s Stargardt disease treatment gets European orphan drug designation

June 27, 2018
The European Medicines Agency has granted orphan drug designation to Lin BioScience’s Stargardt disease treatment, the company announced in a…

In the Journals

Vitamin A supplementation may slow loss of cone function in children with retinitis pigmentosa

June 26, 2018
Children with retinitis pigmentosa who took vitamin A supplementation experienced a slower rate of loss of cone function compared with patients who…

Magnifying lens improves vision, quality of life in patients with advanced AMD and cataract

June 25, 2018
A novel high-add IOL is a promising option for patients with advanced age-related macular degeneration and cataract, according to one surgeon…

LumiThera LT-300 granted CE mark for treating dry AMD

June 25, 2018
The European Union has granted a CE mark for the LT-300 light delivery system, a treatment device for dry age-related macular degeneration, LumiThera…

Acucela’s oral DR formulation shows potential to reduce retinal thickness

June 22, 2018
Oral emixustat hydrochloride reduced central subfield retinal thickness more than placebo in patients with proliferative diabetic retinopathy, with…

In the Journals

Early VA gain predictive of visual response after dexamethasone treatment

June 21, 2018
Early visual acuity gain of 10 or more letters was predictive of a sustained response at 24 months after intravitreal dexamethasone treatment of…

First Argentinian patient receives EyeMax Mono lens for AMD

June 19, 2018
The first EyeMax Mono lens implant procedure for age-related macular degeneration was performed in Argentina, LEH Pharma announced in a press…

More Headlines »